Thrombosis and Hemostasis Biomarkers Market by Product, Test Location, Test Type, Application, End-use, Country, and Region: Industry Analysis, Market Size, Market Share, and Forecast from 2025-2032

Description

REPORT HIGHLIGHT

The Thrombosis and Hemostasis Biomarkers Market was valued at USD 5,482 million in 2024, growing at a CAGR of 6.40% from 2025 to 2032.

Thrombosis and hemostasis biomarkers are laboratory parameters derived from hemostatic system components such as von Willebrand factor (vWF), fibrinogen, and D-dimer. These biomarkers are useful in detecting specific diseases or their pathophysiological effects and have a variety of clinical applications. They are useful for estimating risk and diagnosing venous thromboembolism (VTE) and other conditions. They also aid in the prediction of thrombotic events in lymphoma patients, the response to chemotherapy in pancreatic cancer patients, and better patient management.

Thrombosis and Hemostasis Biomarkers Market- Market Dynamics

Increasing Demand for Personalised Medicines Fuels the Thrombosis and Hemostasis Biomarkers

The growing demand for personalised medicines is expected to drive the thrombosis and hemostasis biomarkers market. Biomarkers enable healthcare providers to create personalised treatment plans that are more effective and safer for each individual. Personalised medicines are based on the principle of curating personalised medical treatment for individuals with unique genetic makeup and medical history; thus, thrombosis and hemostasis biomarkers aid in the identification of patients at a higher risk of blood clots. According to researchers at Japan's Tohoku University, a newly discovered combination of genetic markers can help people with IBD or inflammatory bowel disease avoid blood clotting complications. This condition affects up to 2,10,000 people in Japan today.

Based on the promise of biomarkers and personalised medicine, the British Heart Foundation has funded research to transform heart treatments. According to the publication, new funding for personalised medicine has the potential to transform heart treatment in four key ways. These include developing digital hearts to predict treatment success, designing personalised pacemakers, using personalised medicine to prevent heart attacks and strokes, and predicting the effects of chemotherapy on the heart.

Thrombosis and Hemostasis Biomarkers Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 6.40% from 2025-2032.

According to Product segmentation, the reagents and consumables segment held the highest revenue

In 2024, the clinical laboratory test segment was the most popular Test Location segmentation.

Indoor Networking now dominates the Thrombosis and Hemostasis Biomarkers business, according to Test Type segmentation.

In 2024, Deep Vein Thrombosis (DVT) was the most dominant Application segment.

In 2024, Diagnostic centers were the most popular sort of End-use segmentation.

On the basis of region, North America was the leading revenue generator in 2024

Thrombosis and Hemostasis Biomarkers Market- Segmentation Analysis:

The Global Thrombosis and Hemostasis Biomarkers Market is segmented into six categories: product, test location, test type, application, end-use, and region.

The market is divided into two segments based on Products: analysers, and Reagents and consumables. In the thrombosis and hemostasis biomarkers market, the reagents and consumables segment had the largest market share in 2024 and is expected to be the fastest-growing segment during the forecast period. The increasing prevalence of bleeding and coagulation disorders, high demand for diagnostic tools, and new product launches have all contributed to the segment's dominance.

The market is classified into two segments based on Test Location: Point-of-Care Tests, and Clinical Laboratory Tests. In 2024, the clinical laboratory test segment dominated the thrombosis and hemostasis biomarkers market. Clinical laboratory tests assist in identifying abnormalities in the blood clotting process, determining the severity of the condition, and guiding treatment decisions. Furthermore, increased investment in healthcare infrastructure, particularly in emerging economies, is fueling the expansion of the clinical laboratory tests segment.

Thrombosis and Hemostasis Biomarkers Market- Geographical Insights

Geographically, this market encompasses the Middle East, Africa, Latin America, Asia Pacific, North America, and Europe. These zones are further split based on which countries bring business. In 2024, North America dominated the thrombosis and hemostasis biomarkers market 2024. The region's market is being driven by an increasing prevalence of thrombosis and hemostasis disorders, technological advancements, and consistent R&D efforts in thrombosis and hemostasis biomarkers. For instance, the region's annual incidence of Venous Thromboembolism (VTE) is estimated to be between 104 and 183 cases per 100,000 people. Furthermore, in the United States, 10% to 30% of patients in intensive care units develop disseminated intravascular coagulation. At last, rising demand for personalised medicines and favorable government initiatives are driving the hemostasis and thrombosis industry in the region.

Asia-Pacific is expected to experience the fastest growth in the thrombosis and hemostasis biomarker market during the forecast period, owing to the local presence of leading companies and increased R&D investment. Furthermore, the growing geriatric population, as well as the rising prevalence of cardiovascular and blood clotting disorders, are expected to drive the Asia Pacific regional market. According to research published in Science Direct, there were 18.6 million CVD deaths worldwide in 2019, with Asia Pacific accounting for 58% of the total. Favorable reimbursement policies in Asia Pacific for thrombosis and hemostasis biomarker testing are influencing the regional market.

Thrombosis and Hemostasis Biomarkers Market- Competitive Landscape:

The market for thrombosis and hemostasis biomarkers is characterised by a number of dominant players and ongoing innovation in the pursuit of improved diagnostic efficacy and patient outcomes. BioMerieux SA, F. Hoffmann-La Roche Ltd., Biomedica Diagnostics, Siemens Healthineers, and HORIBA Ltd. are among the market leaders, offering a range of biomarker tests for the early detection and treatment of thrombotic diseases. These companies are committed to innovating their product portfolios through research and development, which includes increasing assay sensitivity and specificity while remaining regulatory compliant. Furthermore, the rising incidence of cardiovascular diseases, as well as the demand for personalised medicine, are driving competition, with companies developing new biomarkers and diagnostic solutions on an integrated platform to meet changing healthcare providers' and patients' needs. For instance, in June 2024, HORIBA has announced the release of its new Yumizen H550 compact hematology analyzers, which incorporate ESR and CBC/Diff features. The new range is aimed at small to mid-throughput laboratories, offering cost-effective, adaptable hematology solutions in the thrombosis and hemostasis biomarkers industry.

Recent Developments:

In March 2023, F. Hoffman-La Roche Ltd. worked with Eli-Lily and Company to advance the Elecsys Amyloid Plasma Panel (EAPP) development. The partnership is expected to improve the company's thrombosis and hemostasis biomarker portfolio.

In April 2024, Siemens Healthcare Private Limited and Sysmex Corporation began distributing a diverse hemostasis testing portfolio to laboratories in the United States and Europe.

In April 2024, Haemonetics Corporation has received FDA 510(k) clearance for its TEG 6s hemostasis analyzer system assay cartridge. This increased the company's TEG 6s viscoelastic testing capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott
bioMerieux SA
F. Hoffmann-La Roche Ltd.
Biomedica Diagnostics
Siemens Healthineers
HORIBA Ltd.
Werfen
Quidel Corporation
Diazyme Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Others

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Analyzers
Reagents & Consumables

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY TEST LOCATION- MARKET ANALYSIS, 2019 - 2032

Point-of-Care Tests
Clinical Laboratory Tests

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

D-Dimer
Anti-Thrombin III
Plasminogen
Selectins
Soluble Fibrin
Factor VIII
PT
APTT
Fibrinogen
Others

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Deep Vein Thrombosis (DVT)
Disseminated Intravascular Coagulation (DIC)
Pulmonary Embolism (PE)
Others

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Diagnostic Centers
Academic & Research Institutes
Others

GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4972

1. Thrombosis and Hemostasis Biomarkers Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Thrombosis and Hemostasis Biomarkers Market Snippet by Product
- 2.1.2. Thrombosis and Hemostasis Biomarkers Market Snippet by Test Location
- 2.1.3. Thrombosis and Hemostasis Biomarkers Market Snippet by Test Type
- 2.1.4. Thrombosis and Hemostasis Biomarkers Market Snippet by Application
- 2.1.5. Thrombosis and Hemostasis Biomarkers Market Snippet by End-use
- 2.1.6. Thrombosis and Hemostasis Biomarkers Market Snippet by Country
- 2.1.7. Thrombosis and Hemostasis Biomarkers Market Snippet by Region
2.2. Competitive Insights

3. Thrombosis and Hemostasis Biomarkers Key Market Trends

3.1. Thrombosis and Hemostasis Biomarkers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Thrombosis and Hemostasis Biomarkers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Thrombosis and Hemostasis Biomarkers Market Opportunities
3.4. Thrombosis and Hemostasis Biomarkers Market Future Trends

4. Thrombosis and Hemostasis Biomarkers Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Thrombosis and Hemostasis Biomarkers Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Thrombosis and Hemostasis Biomarkers Market Landscape

6.1. Thrombosis and Hemostasis Biomarkers Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Thrombosis and Hemostasis Biomarkers Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Analyzers
- 7.1.3. Reagents & Consumables

8. Thrombosis and Hemostasis Biomarkers Market - By Test Location

8.1. Overview
- 8.1.1. Segment Share Analysis, By Test Location, 2024 & 2032 (%)
- 8.1.2. Point-of-Care Tests
- 8.1.3. Clinical Laboratory Tests

9. Thrombosis and Hemostasis Biomarkers Market - By Test Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
- 9.1.2. D-Dimer
- 9.1.3. Anti-Thrombin III
- 9.1.4. Plasminogen
- 9.1.5. Selectins
- 9.1.6. Soluble Fibrin
- 9.1.7. Factor VIII
- 9.1.8. PT
- 9.1.9. APTT
- 9.1.10. Fibrinogen
- 9.1.11. Others

10. Thrombosis and Hemostasis Biomarkers Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Deep Vein Thrombosis (DVT)
- 10.1.3. Disseminated Intravascular Coagulation (DIC)
- 10.1.4. Pulmonary Embolism (PE)
- 10.1.5. Others

11. Thrombosis and Hemostasis Biomarkers Market - By End-use

11.1. Overview
- 11.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
- 11.1.2. Hospitals & Clinics
- 11.1.3. Diagnostic Centers
- 11.1.4. Academic & Research Institutes
- 11.1.5. Others

12. Thrombosis and Hemostasis Biomarkers Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Thrombosis and Hemostasis Biomarkers Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Abbott
- 13.2.2. bioMerieux SA
- 13.2.3. F. Hoffmann-La Roche Ltd.
- 13.2.4. Biomedica Diagnostics
- 13.2.5. Siemens Healthineers
- 13.2.6. HORIBA Ltd.
- 13.2.7. Werfen
- 13.2.8. Quidel Corporation
- 13.2.9. Diazyme Laboratories, Inc.
- 13.2.10. Thermo Fisher Scientific, Inc.
- 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us